MedTrace Logo

Investigating the Use of Fluorescence Imaging in Endometrial Cancer Surgery

NCT01562106 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 123

Last updated 2016-11-18

No results posted yet for this study

Summary

The main purpose of the study is to evaluate the detection rate and accuracy of fluorescence imaging in endometrial cancer staging by sentinel node assessment.

Conditions

Interventions

PROCEDURE

Fluorescence-guided sentinel lymph node detection

During standard endometrial cancer surgery, ICG dye will be injected into the cervix to identify sentinel lymph nodes in the pelvis.

Sponsors & Collaborators

  • Swedish Medical Center

    lead OTHER

Principal Investigators

  • Pamela Paley, MD · Swedish Medical Center

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2015-09-30
Completion
2016-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01562106 on ClinicalTrials.gov